The experimental drug remdesivir was approved to treat hospitalized patients with severe Covid-19 by the FDA who issued an emergency-use authorization (EAU). This is the only approved treatment to date. Remdesivir hasn't undergone the same level of rigorous review as it would in a more typical FDA-approval process. But, clinical trials are ongoing. The U.S. government is starting to distribute the limited number of doses across the country. Other treatment options, such as hydroxychloroquine continue to be studied by experts.
See All FAQs about Coronavirus